{"transactions":[{"id":714432,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-07-06T20:14:27.000Z","date":"2026-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":10297,"price":5.74,"value":59104.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":1272767,"source":{"system":"sec-edgar","filing":"0001628908-26-000070","document":"wk-form4_1783368865.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890826000070/wk-form4_1783368865.xml","form_type":"4"}},{"id":714431,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-07-06T20:14:27.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":446102,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted to Mr. Blackley pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a portion of the award approved by the Compensation Committee of the Company's Board of Directors as part of the annual award cycle. The first portion of the award was granted on March 2, 2026, and this portion of the award was granted on July 1, 2026, following the issuance of additional shares under the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. The Company's shareholders approved the issuance of additional shares under the Amended and Restated 2015 Omnibus Incentive Compensation Plan on June 4, 2026, at the Company's Annual Meeting."},{"field":"shares","element":"transactionShares","label":"F3","text":"Securities vest at a rate of 34% on July 1, 2027, and 33% on July 1, 2028, and July 1, 2029."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":1283064,"source":{"system":"sec-edgar","filing":"0001628908-26-000070","document":"wk-form4_1783368865.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890826000070/wk-form4_1783368865.xml","form_type":"4"}},{"id":860650,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance-Based Share Unit","published_at":"2026-03-04T23:02:31.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":1425310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Represents performance-based share units (PSUs) granted to Mr. Blackley pursuant to the Evolent Health, Inc. Amended and Restated 2015 Omnibus Incentive Compensation Plan. The PSUs may be earned based on the achievement of certain stock price performance conditions from March 1, 2027 to February 28, 2029, subject to satisfying certain service-based conditions.  Each PSU is shown at the target level, and the actual amount earned after completion of the performance period may range from 0% to 250% of the target level."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represents performance-based share units (PSUs) granted to Mr. Blackley pursuant to the Evolent Health, Inc. Amended and Restated 2015 Omnibus Incentive Compensation Plan. The PSUs may be earned based on the achievement of certain stock price performance conditions from March 1, 2027 to February 28, 2029, subject to satisfying certain service-based conditions.  Each PSU is shown at the target level, and the actual amount earned after completion of the performance period may range from 0% to 250% of the target level."}],"balance_after":1425310,"derivative":{"exercise_date":"2027-03-01","expiration_date":"2029-02-28","underlying":"Class A Common Stock","underlying_shares":1425310},"source":{"system":"sec-edgar","filing":"0001628908-26-000023","document":"wk-form4_1772665349.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890826000023/wk-form4_1772665349.xml","form_type":"4"}},{"id":860649,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-04T23:02:31.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":24053,"price":3.51,"value":84426.03,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":836962,"source":{"system":"sec-edgar","filing":"0001628908-26-000023","document":"wk-form4_1772665349.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890826000023/wk-form4_1772665349.xml","form_type":"4"}},{"id":860648,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-04T23:02:31.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":17736,"price":3.58,"value":63494.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon settlement of performance-based share units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":861015,"source":{"system":"sec-edgar","filing":"0001628908-26-000023","document":"wk-form4_1772665349.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890826000023/wk-form4_1772665349.xml","form_type":"4"}},{"id":860647,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-04T23:02:31.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":58921,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares received upon the settlement of the performance-based share units (PSUs) awarded to the reporting person on March 1, 2024, following the certification of achievement of specified performance metrics by the Compensation Committee of the Company's Board of Directors on March 2, 2026. The shares underlying the PSU award vested at the conclusion of the performance period on December 31, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":878751,"source":{"system":"sec-edgar","filing":"0001628908-26-000023","document":"wk-form4_1772665349.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890826000023/wk-form4_1772665349.xml","form_type":"4"}},{"id":860646,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-04T23:02:31.000Z","date":"2026-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":9537,"price":3.25,"value":30995.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":819830,"source":{"system":"sec-edgar","filing":"0001628908-26-000023","document":"wk-form4_1772665349.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890826000023/wk-form4_1772665349.xml","form_type":"4"}},{"id":1091818,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-07-03T11:12:25.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":67150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted to Mr. Blackley pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"Securities vest at a rate of 34% on July 1, 2026, and 33% on July 1, 2027, and July 1, 2028."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents a portion of the award approved by the Compensation Committee of the Company's Board of Directors as part of the annual award cycle.  The first portion of the award was granted on March 3, 2025, and this portion of the award was contingent upon the approval of the issuance of additional shares under the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.  The Company's shareholders approved the issuance of additional shares under the Amended and Restated 2015 Omnibus Incentive Compensation Plan on June 5, 2025, at the Company's Annual Meeting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":829367,"source":{"system":"sec-edgar","filing":"0001628908-25-000107","document":"wk-form4_1751541136.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890825000107/wk-form4_1751541136.xml","form_type":"4"}},{"id":1214445,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-03-10T12:11:43.000Z","date":"2025-03-06","kind":"purchase","planned":false,"acquired":true,"shares":55225,"price":9.01,"value":497577.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.74-9.34, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":762217,"source":{"system":"sec-edgar","filing":"0001628908-25-000044","document":"wk-form4_1741608697.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890825000044/wk-form4_1741608697.xml","form_type":"4"}},{"id":1226256,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-03-04T23:12:42.000Z","date":"2025-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":72768,"price":8.77,"value":638175.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon settlement of performance-based share units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":706992,"source":{"system":"sec-edgar","filing":"0001628908-25-000024","document":"wk-form4_1741129956.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890825000024/wk-form4_1741129956.xml","form_type":"4"}},{"id":1226255,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-03-04T23:12:42.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":161346,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents the number of shares received upon the settlement of the performance-based share units (PSUs) awarded to the reporting person on March 1, 2022, following the certification of\nachievement of specified performance metrics by the Compensation Committee of the Company's Board of Directors on March 3, 2025. The shares underlying the PSU award vested at the conclusion of\nthe performance period on December 31, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":779760,"source":{"system":"sec-edgar","filing":"0001628908-25-000024","document":"wk-form4_1741129956.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890825000024/wk-form4_1741129956.xml","form_type":"4"}},{"id":1226254,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-03-04T23:12:42.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":235025,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents restricted stock units granted to Mr. Blackley pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan."},{"field":"shares","element":"transactionShares","label":"F4","text":"Securities vest at a rate of 34% on March 3, 2026, and 33% on March 3, 2027, and March 3, 2028."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":618414,"source":{"system":"sec-edgar","filing":"0001628908-25-000024","document":"wk-form4_1741129956.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890825000024/wk-form4_1741129956.xml","form_type":"4"}},{"id":1226253,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-03-04T23:12:42.000Z","date":"2025-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":28535,"price":8.99,"value":256529.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":383389,"source":{"system":"sec-edgar","filing":"0001628908-25-000024","document":"wk-form4_1741129956.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890825000024/wk-form4_1741129956.xml","form_type":"4"}},{"id":1422964,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock Option (right to buy)","published_at":"2024-08-27T00:13:20.000Z","date":"2024-08-22","kind":"exercise","planned":true,"acquired":false,"shares":52742,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 29, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The Class A Common Stock Options exercised vested on March 1, 2020."}],"balance_after":0,"derivative":{"exercise_price":10.27,"expiration_date":"2026-03-01","underlying":"Class A Common Stock","underlying_shares":52742},"source":{"system":"sec-edgar","filing":"0001628908-24-000096","document":"wk-form4_1724717593.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890824000096/wk-form4_1724717593.xml","form_type":"4"}},{"id":1422963,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock Option (right to buy)","published_at":"2024-08-27T00:13:20.000Z","date":"2024-08-22","kind":"exercise","planned":true,"acquired":false,"shares":35162,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 29, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The Class A Common Stock Options exercised vested on March 1, 2019 and March 1, 2020."}],"balance_after":0,"derivative":{"exercise_price":10.27,"expiration_date":"2026-03-01","underlying":"Class A Common Stock","underlying_shares":35162},"source":{"system":"sec-edgar","filing":"0001628908-24-000096","document":"wk-form4_1724717593.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890824000096/wk-form4_1724717593.xml","form_type":"4"}},{"id":1422962,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock Option (right to buy)","published_at":"2024-08-27T00:13:20.000Z","date":"2024-08-22","kind":"exercise","planned":true,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 29, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Class A Common Stock Options exercised vested on February 1, 2019."}],"balance_after":0,"derivative":{"exercise_price":6.87,"expiration_date":"2025-02-01","underlying":"Class A Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001628908-24-000096","document":"wk-form4_1724717593.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890824000096/wk-form4_1724717593.xml","form_type":"4"}},{"id":1422961,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-08-27T00:13:20.000Z","date":"2024-08-22","kind":"sale","planned":true,"acquired":false,"shares":187904,"price":30,"value":5637120.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 29, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.02, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":411924,"source":{"system":"sec-edgar","filing":"0001628908-24-000096","document":"wk-form4_1724717593.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890824000096/wk-form4_1724717593.xml","form_type":"4"}},{"id":1422960,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-08-27T00:13:20.000Z","date":"2024-08-22","kind":"exercise","planned":true,"acquired":true,"shares":52742,"price":10.27,"value":541660.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 29, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":599828,"source":{"system":"sec-edgar","filing":"0001628908-24-000096","document":"wk-form4_1724717593.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890824000096/wk-form4_1724717593.xml","form_type":"4"}},{"id":1422959,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-08-27T00:13:20.000Z","date":"2024-08-22","kind":"exercise","planned":true,"acquired":true,"shares":35162,"price":10.27,"value":361113.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 29, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":547086,"source":{"system":"sec-edgar","filing":"0001628908-24-000096","document":"wk-form4_1724717593.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890824000096/wk-form4_1724717593.xml","form_type":"4"}},{"id":1422958,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-08-27T00:13:20.000Z","date":"2024-08-22","kind":"exercise","planned":true,"acquired":true,"shares":100000,"price":6.87,"value":687000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 29, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Since the date of the reporting person's last ownership report, Mr. Blackley transferred 348,458 shares of Evolent Health, Inc. Class A Common Stock pursuant to a domestic relations order. Mr. Blackley no longer reports as beneficially owned any securities owned by his ex-spouse."}],"balance_after":511924,"source":{"system":"sec-edgar","filing":"0001628908-24-000096","document":"wk-form4_1724717593.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890824000096/wk-form4_1724717593.xml","form_type":"4"}},{"id":1594035,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-03-06T00:06:39.000Z","date":"2024-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":24005,"price":34.41,"value":826012.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":760382,"source":{"system":"sec-edgar","filing":"0001628908-24-000032","document":"wk-form4_1709683577.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890824000032/wk-form4_1709683577.xml","form_type":"4"}},{"id":1594034,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-03-06T00:06:39.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":29096,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted to Mr. Blackley pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"Securities vest at a rate of 34% on March 1, 2025, and 33% on March 1, 2026, and March 1, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":784387,"source":{"system":"sec-edgar","filing":"0001628908-24-000032","document":"wk-form4_1709683577.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890824000032/wk-form4_1709683577.xml","form_type":"4"}},{"id":1618594,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-02-26T21:48:11.000Z","date":"2024-02-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":88563,"price":33.03,"value":2925235.89,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of performance stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":755291,"source":{"system":"sec-edgar","filing":"0001628908-24-000025","document":"wk-form4_1708984079.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890824000025/wk-form4_1708984079.xml","form_type":"4"}},{"id":1618593,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-02-26T21:48:11.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":206209,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares received upon the settlement of the second tranche of performance-based share units (PSUs) awarded to the reporting person on March 1, 2021, following the certification of achievement of specified performance metrics. The shares underlying the second tranche of the PSU award vested at the conclusion of the performance period on December 31, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":843854,"source":{"system":"sec-edgar","filing":"0001628908-24-000025","document":"wk-form4_1708984079.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890824000025/wk-form4_1708984079.xml","form_type":"4"}},{"id":1719756,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Leveraged Restricted Stock Unit","published_at":"2023-12-06T21:49:48.000Z","date":"2023-12-04","kind":"exercise","planned":true,"acquired":false,"shares":280000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"These LSUs vested on December 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"These LSUs do not expire."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":280000},"source":{"system":"sec-edgar","filing":"0001628908-23-000185","document":"wk-form4_1701899379.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890823000185/wk-form4_1701899379.xml","form_type":"4"}},{"id":1719755,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-12-06T21:49:48.000Z","date":"2023-12-05","kind":"sale","planned":true,"acquired":false,"shares":20900,"price":27.25,"value":569525.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2023."},{"field":"shares","element":"transactionShares","label":"F5","text":"This number represents shares of Class A Common Stock sold to satisfy the tax withholding obligation due upon vesting of LSUs."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.07 to $27.42, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":637645,"source":{"system":"sec-edgar","filing":"0001628908-23-000185","document":"wk-form4_1701899379.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890823000185/wk-form4_1701899379.xml","form_type":"4"}},{"id":1719754,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-12-06T21:49:48.000Z","date":"2023-12-05","kind":"sale","planned":true,"acquired":false,"shares":92616,"price":26.61,"value":2464511.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2023."},{"field":"shares","element":"transactionShares","label":"F5","text":"This number represents shares of Class A Common Stock sold to satisfy the tax withholding obligation due upon vesting of LSUs."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.05 to $27.04, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":658545,"source":{"system":"sec-edgar","filing":"0001628908-23-000185","document":"wk-form4_1701899379.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890823000185/wk-form4_1701899379.xml","form_type":"4"}},{"id":1719753,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-12-06T21:49:48.000Z","date":"2023-12-05","kind":"sale","planned":true,"acquired":false,"shares":27484,"price":25.74,"value":707438.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2023."},{"field":"shares","element":"transactionShares","label":"F5","text":"This number represents shares of Class A Common Stock sold to satisfy the tax withholding obligation due upon vesting of LSUs."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.05 to $26.04, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":751161,"source":{"system":"sec-edgar","filing":"0001628908-23-000185","document":"wk-form4_1701899379.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890823000185/wk-form4_1701899379.xml","form_type":"4"}},{"id":1719752,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-12-06T21:49:48.000Z","date":"2023-12-04","kind":"exercise","planned":true,"acquired":true,"shares":280000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the vesting of the leveraged stock units (\"LSUs\") granted to Mr. Blackley on June 4, 2020, based on the cumulative performance of the Issuer's Class A Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Since the date of the reporting person's last ownership report, Mr. Blackley transferred 284,366 shares of Evolent Health, Inc. Class A Common Stock pursuant to a domestic relations order."}],"balance_after":778645,"source":{"system":"sec-edgar","filing":"0001628908-23-000185","document":"wk-form4_1701899379.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890823000185/wk-form4_1701899379.xml","form_type":"4"}},{"id":1840808,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Option (right to buy)","published_at":"2023-06-30T20:27:19.000Z","date":"2023-06-28","kind":"exercise","planned":true,"acquired":false,"shares":33011,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Class A Common Stock Options exercised vested on December 1, 2017."}],"balance_after":0,"derivative":{"exercise_price":3.84,"expiration_date":"2024-04-01","underlying":"Class A Common Stock","underlying_shares":33011},"source":{"system":"sec-edgar","filing":"0001628908-23-000107","document":"wf-form4_168815682764495.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890823000107/wf-form4_168815682764495.xml","form_type":"4"}},{"id":1840807,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-06-30T20:27:19.000Z","date":"2023-06-28","kind":"sale","planned":true,"acquired":false,"shares":8469,"price":31.15,"value":263809.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.02 to $31.30, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":783011,"source":{"system":"sec-edgar","filing":"0001628908-23-000107","document":"wf-form4_168815682764495.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890823000107/wf-form4_168815682764495.xml","form_type":"4"}},{"id":1840806,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-06-30T20:27:19.000Z","date":"2023-06-28","kind":"sale","planned":true,"acquired":false,"shares":24542,"price":30.65,"value":752212.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.02 to $31.01, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":791480,"source":{"system":"sec-edgar","filing":"0001628908-23-000107","document":"wf-form4_168815682764495.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890823000107/wf-form4_168815682764495.xml","form_type":"4"}},{"id":1840805,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-06-30T20:27:19.000Z","date":"2023-06-28","kind":"exercise","planned":true,"acquired":true,"shares":33011,"price":3.84,"value":126762.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":816022,"source":{"system":"sec-edgar","filing":"0001628908-23-000107","document":"wf-form4_168815682764495.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890823000107/wf-form4_168815682764495.xml","form_type":"4"}},{"id":1848738,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Option (right to buy)","published_at":"2023-06-20T20:36:41.000Z","date":"2023-06-16","kind":"exercise","planned":true,"acquired":false,"shares":2098,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Class A Common Stock Options exercised vested on December 1, 2017."}],"balance_after":33011,"derivative":{"exercise_price":3.84,"expiration_date":"2024-04-01","underlying":"Class A Common Stock","underlying_shares":2098},"source":{"system":"sec-edgar","filing":"0001628908-23-000105","document":"wf-form4_168729338294086.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890823000105/wf-form4_168729338294086.xml","form_type":"4"}},{"id":1848737,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Option (right to buy)","published_at":"2023-06-20T20:36:41.000Z","date":"2023-06-15","kind":"exercise","planned":true,"acquired":false,"shares":75931,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Class A Common Stock Options exercised vested on December 1, 2017."}],"balance_after":35109,"derivative":{"exercise_price":3.84,"expiration_date":"2024-04-01","underlying":"Class A Common Stock","underlying_shares":75931},"source":{"system":"sec-edgar","filing":"0001628908-23-000105","document":"wf-form4_168729338294086.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890823000105/wf-form4_168729338294086.xml","form_type":"4"}},{"id":1848736,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-06-20T20:36:41.000Z","date":"2023-06-16","kind":"sale","planned":true,"acquired":false,"shares":2098,"price":30.16,"value":63275.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.09 to $30.16, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":783011,"source":{"system":"sec-edgar","filing":"0001628908-23-000105","document":"wf-form4_168729338294086.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890823000105/wf-form4_168729338294086.xml","form_type":"4"}},{"id":1848735,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-06-20T20:36:41.000Z","date":"2023-06-16","kind":"exercise","planned":true,"acquired":true,"shares":2098,"price":3.84,"value":8056.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":785109,"source":{"system":"sec-edgar","filing":"0001628908-23-000105","document":"wf-form4_168729338294086.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890823000105/wf-form4_168729338294086.xml","form_type":"4"}},{"id":1848734,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-06-20T20:36:41.000Z","date":"2023-06-15","kind":"sale","planned":true,"acquired":false,"shares":75931,"price":30.2,"value":2293116.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.52, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":783011,"source":{"system":"sec-edgar","filing":"0001628908-23-000105","document":"wf-form4_168729338294086.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890823000105/wf-form4_168729338294086.xml","form_type":"4"}},{"id":1848733,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-06-20T20:36:41.000Z","date":"2023-06-15","kind":"exercise","planned":true,"acquired":true,"shares":75931,"price":3.84,"value":291575.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":858942,"source":{"system":"sec-edgar","filing":"0001628908-23-000105","document":"wf-form4_168729338294086.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890823000105/wf-form4_168729338294086.xml","form_type":"4"}},{"id":1964920,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Leveraged Restricted Stock Unit","published_at":"2023-03-07T23:06:34.000Z","date":"2023-03-03","kind":"exercise","acquired":false,"shares":360000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"LSUs vested on March 3, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"These LSUs do not expire."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":360000},"source":{"system":"sec-edgar","filing":"0001628908-23-000047","document":"wf-form4_167823038064797.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890823000047/wf-form4_167823038064797.xml","form_type":"4"}},{"id":1964919,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-03-07T23:06:34.000Z","date":"2023-03-07","kind":"sale","acquired":false,"shares":95055,"price":34.62,"value":3290804.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This number represents shares of Class A Common Stock sold to satisfy the tax withholding obligation due upon vesting of LSUs."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.35 to $34.92, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":783011,"source":{"system":"sec-edgar","filing":"0001628908-23-000047","document":"wf-form4_167823038064797.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890823000047/wf-form4_167823038064797.xml","form_type":"4"}},{"id":1964918,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-03-07T23:06:34.000Z","date":"2023-03-06","kind":"sale","acquired":false,"shares":2012,"price":35.01,"value":70440.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This number represents shares of Class A Common Stock sold to satisfy the tax withholding obligation due upon vesting of LSUs."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.975 to $35.060, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":878066,"source":{"system":"sec-edgar","filing":"0001628908-23-000047","document":"wf-form4_167823038064797.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890823000047/wf-form4_167823038064797.xml","form_type":"4"}},{"id":1964917,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-03-07T23:06:34.000Z","date":"2023-03-06","kind":"sale","acquired":false,"shares":71916,"price":34.4,"value":2473910.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This number represents shares of Class A Common Stock sold to satisfy the tax withholding obligation due upon vesting of LSUs."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.95 to $34.93, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":880078,"source":{"system":"sec-edgar","filing":"0001628908-23-000047","document":"wf-form4_167823038064797.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890823000047/wf-form4_167823038064797.xml","form_type":"4"}},{"id":1964916,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-03-07T23:06:34.000Z","date":"2023-03-03","kind":"exercise","acquired":true,"shares":360000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the vesting of the leveraged stock units (\"LSUs\") granted to Mr. Blackley on March 2, 2020, based on the cumulative performance of the Issuer's Class A Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":951994,"source":{"system":"sec-edgar","filing":"0001628908-23-000047","document":"wf-form4_167823038064797.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890823000047/wf-form4_167823038064797.xml","form_type":"4"}},{"id":1971522,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-03-03T22:44:55.000Z","date":"2023-03-01","kind":"tax_withholding","acquired":false,"shares":7470,"price":35.26,"value":263392.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":591994,"source":{"system":"sec-edgar","filing":"0001628908-23-000043","document":"wf-form4_167788347302001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890823000043/wf-form4_167788347302001.xml","form_type":"4"}},{"id":1971521,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-03-03T22:44:55.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":59002,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted to Mr. Blackley pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"Securities vest at a rate of 34% on March 1, 2024, and 33% on March 1, 2025, and March 1, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":599464,"source":{"system":"sec-edgar","filing":"0001628908-23-000043","document":"wf-form4_167788347302001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890823000043/wf-form4_167788347302001.xml","form_type":"4"}},{"id":1995262,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-02-23T23:52:25.000Z","date":"2023-02-21","kind":"tax_withholding","acquired":false,"shares":87786,"price":28.08,"value":2465030.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of PSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":540462,"source":{"system":"sec-edgar","filing":"0001628908-23-000017","document":"wf-form4_167719632820675.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890823000017/wf-form4_167719632820675.xml","form_type":"4"}},{"id":1995261,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-02-23T23:52:25.000Z","date":"2023-02-21","kind":"grant","acquired":true,"shares":206211,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares received upon the settlement of the first tranche of performance-based share units (PSUs) awarded to the reporting person on March 1, 2021, following the certification of achievement of specified performance metrics. The shares underlying the first tranche of the PSU award vested at the conclusion of the performance period on December 31, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":628248,"source":{"system":"sec-edgar","filing":"0001628908-23-000017","document":"wf-form4_167719632820675.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890823000017/wf-form4_167719632820675.xml","form_type":"4"}},{"id":2104883,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Option (right to buy)","published_at":"2022-11-24T00:50:52.000Z","date":"2022-11-21","kind":"exercise","acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 16, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Class A Common Stock Options exercised vested on December 1, 2016, and December 1, 2017."}],"balance_after":111040,"derivative":{"exercise_price":3.84,"expiration_date":"2024-04-01","underlying":"Class A Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001628908-22-000156","document":"wf-form4_166925103286679.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890822000156/wf-form4_166925103286679.xml","form_type":"4"}},{"id":2104882,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2022-11-24T00:50:52.000Z","date":"2022-11-21","kind":"sale","acquired":false,"shares":75000,"price":26.79,"value":2009250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 16, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $26.38 to $27.10, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":422037,"source":{"system":"sec-edgar","filing":"0001628908-22-000156","document":"wf-form4_166925103286679.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890822000156/wf-form4_166925103286679.xml","form_type":"4"}},{"id":2104881,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2022-11-24T00:50:52.000Z","date":"2022-11-21","kind":"exercise","acquired":true,"shares":75000,"price":3.84,"value":288000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 16, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":497037,"source":{"system":"sec-edgar","filing":"0001628908-22-000156","document":"wf-form4_166925103286679.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890822000156/wf-form4_166925103286679.xml","form_type":"4"}},{"id":2349560,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Leveraged Restricted Stock Unit","published_at":"2022-03-05T02:01:29.000Z","date":"2022-03-02","kind":"exercise","acquired":false,"shares":286867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Leveraged Stock Units vested on March 2, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These Leveraged Stock Units do not expire."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":286867},"source":{"system":"sec-edgar","filing":"0001628908-22-000045","document":"wf-form4_164644567295512.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890822000045/wf-form4_164644567295512.xml","form_type":"4"}},{"id":2349559,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2022-03-05T02:01:29.000Z","date":"2022-03-03","kind":"tax_withholding","acquired":false,"shares":129378,"price":27.54,"value":3563070.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of leveraged stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table I of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":422037,"source":{"system":"sec-edgar","filing":"0001628908-22-000045","document":"wf-form4_164644567295512.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890822000045/wf-form4_164644567295512.xml","form_type":"4"}},{"id":2349558,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2022-03-05T02:01:29.000Z","date":"2022-03-02","kind":"exercise","acquired":true,"shares":286867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the vesting of the leveraged stock units granted to Mr. Blackley on March 1, 2019, based on the cumulative performance of the Issuer's Class A Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table I of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":551415,"source":{"system":"sec-edgar","filing":"0001628908-22-000045","document":"wf-form4_164644567295512.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890822000045/wf-form4_164644567295512.xml","form_type":"4"}},{"id":2352640,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2022-03-04T02:25:54.000Z","date":"2022-03-01","kind":"tax_withholding","acquired":false,"shares":5285,"price":27.4,"value":144809.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":264548,"source":{"system":"sec-edgar","filing":"0001628908-22-000035","document":"wf-form4_164636073453327.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890822000035/wf-form4_164636073453327.xml","form_type":"4"}},{"id":2352639,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2022-03-04T02:25:54.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":64991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted to Mr. Blackley pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"Securities vest at a rate of 34% on March 1, 2023, and 33 % on March 1, 2024, and March 1, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":269833,"source":{"system":"sec-edgar","filing":"0001628908-22-000035","document":"wf-form4_164636073453327.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890822000035/wf-form4_164636073453327.xml","form_type":"4"}},{"id":2538785,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Option (right to buy)","published_at":"2021-10-20T01:15:17.000Z","date":"2021-10-15","kind":"exercise","acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Class A Common Stock Options exercised vested on December 1, 2015 and December 1, 2016."}],"balance_after":186040,"derivative":{"exercise_price":3.84,"expiration_date":"2024-04-01","underlying":"Class A Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001628908-21-000135","document":"wf-form4_163469248900793.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890821000135/wf-form4_163469248900793.xml","form_type":"4"}},{"id":2538784,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2021-10-20T01:15:17.000Z","date":"2021-10-15","kind":"sale","acquired":false,"shares":150000,"price":29.86,"value":4479000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.66 to $30.07, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":204842,"source":{"system":"sec-edgar","filing":"0001628908-21-000135","document":"wf-form4_163469248900793.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890821000135/wf-form4_163469248900793.xml","form_type":"4"}},{"id":2538783,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2021-10-20T01:15:17.000Z","date":"2021-10-15","kind":"exercise","acquired":true,"shares":150000,"price":3.84,"value":576000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":354842,"source":{"system":"sec-edgar","filing":"0001628908-21-000135","document":"wf-form4_163469248900793.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890821000135/wf-form4_163469248900793.xml","form_type":"4"}},{"id":2811230,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2021-03-04T01:39:55.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":46866,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted to Mr. Blackley pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"Securities vest at a rate of 25% annually beginning March 1, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":204842,"source":{"system":"sec-edgar","filing":"0001628908-21-000028","document":"wf-form4_161482197473209.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890821000028/wf-form4_161482197473209.xml","form_type":"4"}},{"id":3119851,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Leveraged Restricted Stock Unit","published_at":"2020-06-05T21:48:59.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These securities vest on December 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These securities do not expire."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Each leveraged stock unit (\"LSU\") represents the contingent right to receive, upon vesting, between 0% and 200% of one share of the Issuer's Class A Common Stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired  upon vesting of the LSUs, if any, is based on the cumulative performance of the Issuer's Class A Common Stock."}],"balance_after":140000,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001628908-20-000070","document":"wf-form4_159139372184815.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890820000070/wf-form4_159139372184815.xml","form_type":"4"}},{"id":3226320,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Leveraged Restricted Stock Unit","published_at":"2020-03-04T21:55:11.000Z","date":"2020-03-02","kind":"grant","acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These LSUs vest on March 2, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These LSUs do not expire."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Each leveraged stock unit (\"LSU\") represents the contingent right to receive, upon vesting, between 0% and 200% of one share of the Issuer's Class A common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired  upon vesting of the LSUs, if any, is based on the cumulative performance of the Issuer's Class A common stock."}],"balance_after":180000,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001628908-20-000036","document":"wf-form4_158335889433356.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890820000036/wf-form4_158335889433356.xml","form_type":"4"}},{"id":3350609,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2019-12-05T22:16:42.000Z","date":"2019-12-04","kind":"purchase","acquired":true,"shares":14749,"price":6.73,"value":99260.77,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $ 6.70 to $6.78, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":157976,"source":{"system":"sec-edgar","filing":"0001628908-19-000076","document":"wf-form4_157558418569337.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890819000076/wf-form4_157558418569337.xml","form_type":"4"}},{"id":3610450,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Leveraged Restricted Stock Unit","published_at":"2019-03-05T22:23:12.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":186750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each leveraged stock unit (\"LSU\") represents the contingent right to receive, upon vesting, between 0% and 200% of one share of the Issuer's Class A common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the LSUs, if any, is based on the cumulative performance of the Issuer's Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These LSUs vest on March 2, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These LSUs do not expire."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Each leveraged stock unit (\"LSU\") represents the contingent right to receive, upon vesting, between 0% and 200% of one share of the Issuer's Class A common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the LSUs, if any, is based on the cumulative performance of the Issuer's Class A common stock."}],"balance_after":186750,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":186750},"source":{"system":"sec-edgar","filing":"0001628908-19-000012","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890819000012/primary_doc.xml","form_type":"4"}},{"id":3869885,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Option (Right to Buy)","published_at":"2018-07-10T21:28:01.000Z","date":"2018-07-06","kind":"exercise","acquired":false,"shares":31554,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Class A Common Stock Options exercised vested on December 1, 2015."}],"balance_after":336040,"derivative":{"exercise_price":3.84,"expiration_date":"2024-04-01","underlying":"Class A Common Stock","underlying_shares":31554},"source":{"system":"sec-edgar","filing":"0001628908-18-000058","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890818000058/primary_doc.xml","form_type":"4"}},{"id":3869884,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2018-07-10T21:28:01.000Z","date":"2018-07-06","kind":"sale","acquired":false,"shares":31554,"price":22.74,"value":717537.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $22.55-$23.00, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":143227,"source":{"system":"sec-edgar","filing":"0001628908-18-000058","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890818000058/primary_doc.xml","form_type":"4"}},{"id":3869883,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2018-07-10T21:28:01.000Z","date":"2018-07-06","kind":"exercise","acquired":true,"shares":31554,"price":3.84,"value":121167.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":174781,"source":{"system":"sec-edgar","filing":"0001628908-18-000058","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890818000058/primary_doc.xml","form_type":"4"}},{"id":3869882,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2018-07-10T21:28:01.000Z","date":"2018-07-06","kind":"sale","acquired":false,"shares":20610,"price":22.72,"value":468259.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $22.55-$23.00, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":143227,"source":{"system":"sec-edgar","filing":"0001628908-18-000058","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890818000058/primary_doc.xml","form_type":"4"}},{"id":3871603,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Option (Right to Buy)","published_at":"2018-07-06T20:29:57.000Z","date":"2018-07-05","kind":"exercise","acquired":false,"shares":32643,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The Class A Common Stock Options exercised vested on December 1, 2014 and December 1, 2015."}],"balance_after":367594,"derivative":{"exercise_price":3.84,"expiration_date":"2024-04-01","underlying":"Class A Common Stock","underlying_shares":32643},"source":{"system":"sec-edgar","filing":"0001628908-18-000057","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890818000057/primary_doc.xml","form_type":"4"}},{"id":3871602,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Option (Right to Buy)","published_at":"2018-07-06T20:29:57.000Z","date":"2018-07-03","kind":"exercise","acquired":false,"shares":48930,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Class A Common Stock Options exercised vested on December 1, 2014."}],"balance_after":400237,"derivative":{"exercise_price":3.84,"expiration_date":"2024-04-01","underlying":"Class A Common Stock","underlying_shares":48930},"source":{"system":"sec-edgar","filing":"0001628908-18-000057","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890818000057/primary_doc.xml","form_type":"4"}},{"id":3871601,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2018-07-06T20:29:57.000Z","date":"2018-07-05","kind":"sale","acquired":false,"shares":32643,"price":22.51,"value":734793.93,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $22.250-$22.775, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":163837,"source":{"system":"sec-edgar","filing":"0001628908-18-000057","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890818000057/primary_doc.xml","form_type":"4"}},{"id":3871600,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2018-07-06T20:29:57.000Z","date":"2018-07-05","kind":"exercise","acquired":true,"shares":32643,"price":3.84,"value":125349.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":196480,"source":{"system":"sec-edgar","filing":"0001628908-18-000057","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890818000057/primary_doc.xml","form_type":"4"}},{"id":3871599,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2018-07-06T20:29:57.000Z","date":"2018-07-05","kind":"sale","acquired":false,"shares":33467,"price":22.52,"value":753676.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $22.250-$22.775, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":163837,"source":{"system":"sec-edgar","filing":"0001628908-18-000057","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890818000057/primary_doc.xml","form_type":"4"}},{"id":3871598,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2018-07-06T20:29:57.000Z","date":"2018-07-03","kind":"sale","acquired":false,"shares":48930,"price":22.16,"value":1084288.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $21.60-$22.60, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":197304,"source":{"system":"sec-edgar","filing":"0001628908-18-000057","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890818000057/primary_doc.xml","form_type":"4"}},{"id":3871597,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2018-07-06T20:29:57.000Z","date":"2018-07-03","kind":"exercise","acquired":true,"shares":48930,"price":3.84,"value":187891.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":246234,"source":{"system":"sec-edgar","filing":"0001628908-18-000057","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890818000057/primary_doc.xml","form_type":"4"}},{"id":3871596,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2018-07-06T20:29:57.000Z","date":"2018-07-03","kind":"sale","acquired":false,"shares":49099,"price":22.16,"value":1088033.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $21.60-$22.60, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":197304,"source":{"system":"sec-edgar","filing":"0001628908-18-000057","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890818000057/primary_doc.xml","form_type":"4"}},{"id":3872240,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Option (right to buy)","published_at":"2018-07-05T21:07:56.000Z","date":"2018-07-02","kind":"exercise","acquired":false,"shares":41873,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Class A Common Stock Options exercised vested on December 1, 2014."}],"balance_after":449167,"derivative":{"exercise_price":3.84,"expiration_date":"2024-04-01","underlying":"Class A Common Stock","underlying_shares":41873},"source":{"system":"sec-edgar","filing":"0001628908-18-000056","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890818000056/primary_doc.xml","form_type":"4"}},{"id":3872239,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2018-07-05T21:07:56.000Z","date":"2018-07-02","kind":"sale","acquired":false,"shares":41873,"price":21.22,"value":888545.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $20.65-$21.60, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":246403,"source":{"system":"sec-edgar","filing":"0001628908-18-000056","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890818000056/primary_doc.xml","form_type":"4"}},{"id":3872238,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2018-07-05T21:07:56.000Z","date":"2018-07-02","kind":"exercise","acquired":true,"shares":41873,"price":3.84,"value":160792.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":288276,"source":{"system":"sec-edgar","filing":"0001628908-18-000056","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890818000056/primary_doc.xml","form_type":"4"}},{"id":3872237,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2018-07-05T21:07:56.000Z","date":"2018-07-02","kind":"sale","acquired":false,"shares":41824,"price":21.21,"value":887087.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $20.65-$21.60, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":246403,"source":{"system":"sec-edgar","filing":"0001628908-18-000056","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890818000056/primary_doc.xml","form_type":"4"}},{"id":3886831,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2018-06-20T20:31:50.000Z","date":"2018-06-18","kind":"sale","acquired":false,"shares":16674,"price":23.33,"value":389004.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $23.20-$23.50, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":288227,"source":{"system":"sec-edgar","filing":"0001628908-18-000052","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890818000052/primary_doc.xml","form_type":"4"}},{"id":3902982,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2018-06-06T21:32:48.000Z","date":"2018-06-04","kind":"sale","acquired":false,"shares":2885,"price":20.95,"value":60440.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $20.90-$21.00, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate prices within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":304901,"source":{"system":"sec-edgar","filing":"0001628908-18-000038","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890818000038/primary_doc.xml","form_type":"4"}},{"id":3902981,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2018-06-06T21:32:48.000Z","date":"2018-06-04","kind":"sale","acquired":false,"shares":13781,"price":20.34,"value":280305.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $19.85-$20.85, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":307786,"source":{"system":"sec-edgar","filing":"0001628908-18-000038","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890818000038/primary_doc.xml","form_type":"4"}},{"id":3919949,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2018-05-23T20:40:06.000Z","date":"2018-05-21","kind":"sale","acquired":false,"shares":16666,"price":19.39,"value":323153.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $19.25-$19.55, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":321567,"source":{"system":"sec-edgar","filing":"0001628908-18-000034","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890818000034/primary_doc.xml","form_type":"4"}},{"id":3936568,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2018-05-11T20:48:17.000Z","date":"2018-05-10","kind":"sale","acquired":false,"shares":64398,"price":17.63,"value":1135336.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $17.15-$18.35, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":338233,"source":{"system":"sec-edgar","filing":"0001628908-18-000031","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890818000031/primary_doc.xml","form_type":"4"}},{"id":3940497,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2018-05-09T20:24:05.000Z","date":"2018-05-08","kind":"sale","acquired":false,"shares":5124,"price":17,"value":87108.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":402631,"source":{"system":"sec-edgar","filing":"0001628908-18-000026","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890818000026/primary_doc.xml","form_type":"4"}},{"id":3940496,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2018-05-09T20:24:05.000Z","date":"2018-05-07","kind":"sale","acquired":false,"shares":80472,"price":17.09,"value":1375266.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $17.00-$17.30, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of share sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":407755,"source":{"system":"sec-edgar","filing":"0001628908-18-000026","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890818000026/primary_doc.xml","form_type":"4"}},{"id":4075589,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock Option (right to buy)","published_at":"2018-02-05T21:59:19.000Z","date":"2018-02-01","kind":"grant","acquired":true,"shares":101010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Securities vest at a rate of 25% annually beginning February 1, 2019."}],"balance_after":101010,"derivative":{"exercise_price":13.95,"expiration_date":"2028-02-01","underlying":"Class A Common Stock","underlying_shares":101010},"source":{"system":"sec-edgar","filing":"0001628908-18-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890818000004/primary_doc.xml","form_type":"4"}},{"id":4075588,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2018-02-05T21:59:19.000Z","date":"2018-02-01","kind":"grant","acquired":true,"shares":86022,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted to Mr. Blackley pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"Securities vest at a rate of 25% annually beginning February 1, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":488227,"source":{"system":"sec-edgar","filing":"0001628908-18-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890818000004/primary_doc.xml","form_type":"4"}},{"id":4276930,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2017-06-19T20:15:27.000Z","date":"2017-06-15","kind":"sale","acquired":false,"shares":15000,"price":25.22,"value":378300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $25.00-$25.55, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":402205,"source":{"system":"sec-edgar","filing":"0001628908-17-000033","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890817000033/primary_doc.xml","form_type":"4"}},{"id":4297685,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2017-06-01T20:38:43.000Z","date":"2017-05-30","kind":"sale","acquired":false,"shares":15000,"price":22.86,"value":342900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $22.60-$23.55, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units under awards reported on Table 1 of the Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":417205,"source":{"system":"sec-edgar","filing":"0001643346-17-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000164334617000010/primary_doc.xml","form_type":"4"}},{"id":4307660,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"officer":true,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2017-05-23T22:25:36.000Z","date":"2017-05-19","kind":"sale","acquired":false,"shares":114865,"price":24.3,"value":2791219.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":432205,"source":{"system":"sec-edgar","filing":"0000950157-17-000721","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000095015717000721/form4.xml","form_type":"4"}},{"id":4315070,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2017-05-17T22:05:36.000Z","date":"2017-05-15","kind":"sale","acquired":false,"shares":15000,"price":25,"value":375000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $24.90-$25.35, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":760944,"source":{"system":"sec-edgar","filing":"0001643346-17-000009","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000164334617000009/primary_doc.xml","form_type":"4"}},{"id":4334557,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2017-05-03T20:45:07.000Z","date":"2017-05-01","kind":"sale","acquired":false,"shares":15000,"price":23.11,"value":346650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reported person on September 9, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $22.875-$23.35, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":775944,"source":{"system":"sec-edgar","filing":"0001643346-17-000008","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000164334617000008/primary_doc.xml","form_type":"4"}},{"id":4349320,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2017-04-19T21:37:42.000Z","date":"2017-04-17","kind":"sale","acquired":false,"shares":3658,"price":21.88,"value":80037.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $21.825-$21.925, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":790944,"source":{"system":"sec-edgar","filing":"0001643346-17-000007","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000164334617000007/primary_doc.xml","form_type":"4"}},{"id":4349319,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2017-04-19T21:37:42.000Z","date":"2017-04-17","kind":"sale","acquired":false,"shares":11342,"price":21.35,"value":242151.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $20.80-$21.80, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":794602,"source":{"system":"sec-edgar","filing":"0001643346-17-000007","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000164334617000007/primary_doc.xml","form_type":"4"}},{"id":4366459,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2017-03-31T20:52:52.000Z","date":"2017-03-30","kind":"sale","acquired":false,"shares":1284,"price":21.76,"value":27939.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $21.725-$21.85, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":805944,"source":{"system":"sec-edgar","filing":"0001643346-17-000006","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000164334617000006/primary_doc.xml","form_type":"4"}},{"id":4366458,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2017-03-31T20:52:52.000Z","date":"2017-03-30","kind":"sale","acquired":false,"shares":13716,"price":21.14,"value":289956.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $20.70-$21.65, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":807228,"source":{"system":"sec-edgar","filing":"0001643346-17-000006","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000164334617000006/primary_doc.xml","form_type":"4"}},{"id":4379085,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2017-03-17T20:43:54.000Z","date":"2017-03-15","kind":"sale","acquired":false,"shares":4604,"price":21.29,"value":98019.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $21.20-$21.40, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":820944,"source":{"system":"sec-edgar","filing":"0001643346-17-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000164334617000005/primary_doc.xml","form_type":"4"}},{"id":4379084,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":31975,"kind":"person","name":"Blackley Seth","position":1,"cik":"0001643346","reported_name":"Blackley Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2017-03-17T20:43:54.000Z","date":"2017-03-15","kind":"sale","acquired":false,"shares":10396,"price":20.68,"value":214989.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $20.15-$21.10, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate prices within the range set forth in this footnote."}],"balance_after":825548,"source":{"system":"sec-edgar","filing":"0001643346-17-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000164334617000005/primary_doc.xml","form_type":"4"}}],"next_cursor":"2017-03-17T20:43:54.000000Z,4379084"}